Related Experiment Video
Updated: Jan 21, 2026

In-vivo Detection of Protein-protein Interactions on Micro-patterned Surfaces
Published on: March 19, 2010
Serum protein expression patterns in detecting a new viral protein in HBeAg-negative chronic hepatitis B
Huguang Chen1, Shuya Luo2, Weili Lu3
1Infectious Diseases Department,, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Insights
Researchers identified a specific protein marker in HBeAg-negative chronic hepatitis B (CHB) patients. This finding may help understand the disease
Area of Science:
- Hepatology
- Virology
- Biochemistry
Background:
- Chronic hepatitis B (CHB) is a significant global health concern.
- Hepatitis B e antigen (HBeAg)-negative CHB represents a distinct clinical entity.
- Understanding viral protein expression is crucial for CHB pathogenesis.
Purpose of the Study:
- To analyze viral protein expression changes in HBeAg-negative CHB.
- To identify potential biomarkers associated with HBeAg-negative CHB.
Main Methods:
- Serum samples from 160 individuals were analyzed.
- Participants were categorized into HBeAg-negative CHB, inactive seroconverters, HBeAg-positive CHB, and healthy controls.
- Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) was employed.
Main Results:
- A distinct peak at 4140 m/z was significantly elevated in HBeAg-negative CHB patients.
- This elevated peak showed a significant difference compared to inactive seroconverters.
- The identified peak correlated with hepatitis B virus (HBV) DNA replication.
Conclusions:
- A specific protein marker (4140 m/z) is associated with HBeAg-negative CHB.
- This marker may play a role in the pathogenesis of HBeAg-negative CHB.
- Further research is warranted to elucidate the role of this protein in HBV infection.
Abstract:
We analysed the changes in viral protein expression in HBeAg-negative chronic hepatitis B (CHB). In total, 160 samples were obtained from individuals infected by hepatitis B virus (HBV) and divided into four groups. Group A included 71 cases of hepatitis B e antigen (HBeAg)-negative CHB, Group B included 58 cases of inactive seroconverters and Group C included 31 cases of HBeAg-positive CHB. Group D included 22 normal healthy individuals as a control. All serum samples were examined using surface enhance laser desorption/ionization time of flight-mass spectrometry (SELDI-TOF-MS). The results indicated that a peak with 4140 m/z increased markedly in Group A at 1295.55 ± 745.87, which was significantly different from that in Group B at 896.99 ± 534.86 (P = 0.013). This peak indicated a close relationship with HBV DNA replication and may contribute to pathogenesis of HBeAg-negative chronic hepatitis.
Related Concept Videos
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Gram-negative Bacterial Protein Secretion Systems
What are Proteins?
Protein-protein Interfaces
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...

